Indiana Diabetes Research Center
Indiana Diabetes Research Center
批准号:
10633110
负责人:
Carmella Evans-Molina
金额:
$153.75万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-07-06 至 2025-05-31
关键词:
AdvocateAnimal ExperimentationAnimalsAwardAwarenessBasic ScienceBioinformaticsBiological SciencesBiomedical EngineeringChildClinical ResearchCollaborationsCommunitiesComplications of Diabetes MellitusDevelopmentDiabetes MellitusDiagnosisDiseaseEcosystemEndocrine System DiseasesEnsureEvolutionExtramural ActivitiesFamily suidaeFinancial SupportFosteringFoundationsFundingFutureGenomicsGoalsGrantGrowthHumanIndianaIndividualInfluentialsInformaticsInfrastructureInstitutionKnowledgeLearningMentorsMentorshipMetabolic DiseasesMetabolismMethodological StudiesMicroscopyMissionMolecularNational Institute of Diabetes and Digestive and Kidney DiseasesNutritional StudyObesityPhysiologyPopulationPostdoctoral FellowPrediabetes syndromeProteomicsResearchResearch InfrastructureResearch InstituteResearch MethodologyResearch PersonnelResearch Project GrantsResourcesScientistSeriesStructureStudentsSystemTalentsTrainingTraining SupportTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesVisitbasecatalystcollaborative environmenteducational atmospherehuman subjecthuman tissueinnovationisletmedical schoolsmembermetabolic abnormality assessmentmodel organismnew growthnext generationnovelnutritionprogramssymposiumtranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT (OVERALL CENTER)
The mission of the Indiana Diabetes Research Center (IDRC) is to foster knowledge, support training, and
promote basic and translational research in diabetes and related metabolic disorders, and their complications.
A major focus of the IDRC has been the training and development of the “next generation” of diabetes
researcher. This focus has involved a state-wide effort led by the IDRC that has included resource provision
(through the Research Cores), financial support and mentoring (through the Pilot and Feasibility Program and
institutional funds), and creation of a collaborative diabetes ecosystem (through the Enrichment Program) for a
burgeoning pool of investigators at Indiana University School of Medicine and its affiliated research institutions
in Indiana (Purdue University, Indiana University-Purdue University in Indianapolis, Indiana University
Bloomington, and the Indiana Biosciences Research Institute). The IDRC has been the catalyst for the growth
of the Diabetes Research Base by 47% since the funding of this award in 2015. The IDRC consists of a
Research Base of 94 highly collaborative investigators who represent 4 research themes: Cellular & Molecular
Metabolism; Complications of Diabetes & Obesity; Islet Function & Survival; Nutrition & Physiology of Diabetes
and Obesity. Collectively, this group of investigators brings in $46.7M in annual directs from the NIH, of which
50% ($23M) is from NIDDK. The research programs of these investigators is be augmented by 5 state-of-the-
art Research Cores (Microscopy, Islet & Physiology, Translation, Swine, and Systems & Informatics Cores).
An Enrichment Program, supported by 6 T32 training grants, will enhance learning and discovery. A Pilot and
Feasibility Program will grow the Research Base by providing funding to highly promising young investigators.
An Administrative Core will oversee governance of the IDRC, and will receive input from an Executive
Committee, an Internal Advisory Board, and an External Advisory Board of world-renowned
diabetes/metabolism research leaders. The Aims of the IDRC will be to:
(1) Promote high impact scientific discoveries by leveraging Research Cores that facilitate
collaborations and the use of state-of-the-art methodologies and human studies in diabetes research;
(2) Enhance a highly collaborative environment that promotes learning and encourages interaction
among investigators;
(3) Support the training and innovative research of a burgeoning pool of superb investigators with the
potential to become future leaders in diabetes research;
(4) Build and strengthen the diabetes research base, support infrastructure to ensure ongoing growth
and innovation, and engage with the local community to raise diabetes awareness and involvement.
期刊论文(199)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/pedi.13455
发表时间:
2022-12
期刊:
PEDIATRIC DIABETES
影响因子:
3.4
作者:
[de Bock, Martin, Codner, Ethel, Craig, Maria E., Huynh, Tony, Maahs, David M., Mahmud, Farid H., Marcovecchio, Loredana, DiMeglio, Linda A.]
通讯作者:
DiMeglio, Linda A.
The Yin and Yang of Modulating β-Cell DNA Damage Response and Functional Mass.
调节 β 细胞 DNA 损伤反应和功能质量的阴阳。
DOI:
10.2337/dbi22-0010
发表时间:
2022-08-01
期刊:
Diabetes
影响因子:
7.7
作者:
[]
通讯作者:
DOI:
10.1111/pedi.13441
发表时间:
2022-12
期刊:
PEDIATRIC DIABETES
影响因子:
3.4
作者:
[Craig, Maria E., Codner, Ethel, Mahmud, Farid H., Marcovecchio, M. Loredana, DiMeglio, Linda A., Priyambada, Leena, Wolfsdorf, Joseph I.]
通讯作者:
Wolfsdorf, Joseph I.
Sex discrepancy in the reduction of mucosal-associated invariant T cells caused by obesity.
肥胖引起的粘膜相关不变的T细胞减少性别差异。
DOI:
10.1002/iid3.393
发表时间:
2021-03
期刊:
Immunity, inflammation and disease
影响因子:
--
作者:
[Liu J, Nan H, Brutkiewicz RR, Casasnovas J, Kua KL]
通讯作者:
Kua KL
DOI:
10.14814/phy2.13363
发表时间:
2017-08
期刊:
Physiological reports
影响因子:
2.5
作者:
[Ambery AG, Tackett L, Penque BA, Brozinick JT, Elmendorf JS]
通讯作者:
Elmendorf JS
共 108 条
β cell miRNAs Function as Molecular Hubs of Type 1 Diabetes Pathogenesis
-
批准号:10561855
-
项目类别:
-
资助金额:$4.09万
-
财政年份:2022
-
负责人:Carmella Evans-Molina
-
依托单位:
β cell miRNAs Function as Molecular Hubs of Type 1 Diabetes Pathogenesis
-
批准号:10321295
-
项目类别:
-
资助金额:$42.69万
-
财政年份:2021
-
负责人:Carmella Evans-Molina
-
依托单位:
Control of beta cell function and survival by RYR2-mediated calcium signals
-
批准号:10491304
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2021
-
负责人:Carmella Evans-Molina
-
依托单位:
β cell miRNAs Function as Molecular Hubs of Type 1 Diabetes Pathogenesis
-
批准号:10615586
-
项目类别:
-
资助金额:$42.82万
-
财政年份:2021
-
负责人:Carmella Evans-Molina
-
依托单位:
Control of beta cell function and survival by RYR2-mediated calcium signals
-
批准号:10375087
-
项目类别:
-
资助金额:$47.96万
-
财政年份:2021
-
负责人:Carmella Evans-Molina
-
依托单位:
Control of beta cell function and survival by RYR2-mediated calcium signals
-
批准号:10689291
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2021
-
负责人:Carmella Evans-Molina
-
依托单位:
Indiana University clinical Center for acute pancreatitis and diabetes clinical research network
-
批准号:10458720
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2020
-
负责人:Carmella Evans-Molina
-
依托单位:
Indiana University clinical Center for acute pancreatitis and diabetes clinical research network
-
批准号:10673629
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2020
-
负责人:Carmella Evans-Molina
-
依托单位:
Indiana University clinical Center for acute pancreatitis and diabetes clinical research network
-
批准号:10265585
-
项目类别:
-
资助金额:$27.85万
-
财政年份:2020
-
负责人:Carmella Evans-Molina
-
依托单位:
Islet Core
-
批准号:9105738
-
项目类别:
-
资助金额:$17.16万
-
财政年份:2016
-
负责人:Carmella Evans-Molina
-
依托单位:
Indiana Diabetes Research Center
-
批准号:10286616
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Administrative Core
-
批准号:10155468
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Islet & Physiology Core
-
批准号:10155469
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Islet & Physiology Core
-
批准号:10633119
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Islet Core
-
批准号:8874370
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Indiana Diabetes Research Center
-
批准号:10427462
-
项目类别:
-
资助金额:$153.75万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Islet & Physiology Core
-
批准号:10427464
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Indiana Diabetes Research Center
-
批准号:10155467
-
项目类别:
-
资助金额:$153.75万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Administrative Core
-
批准号:10633112
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
Administrative Core
-
批准号:10427463
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2015
-
负责人:Carmella Evans-Molina
-
依托单位:
海外基金